|1.||Bazhin, Alexandr V: 4 articles (03/2010 - 03/2007)|
|2.||Philippov, Pavel P: 4 articles (03/2010 - 03/2007)|
|3.||Schadendorf, Dirk: 4 articles (03/2010 - 03/2007)|
|4.||Eichmüller, Stefan B: 4 articles (03/2010 - 03/2007)|
|5.||Adamus, Grazyna: 3 articles (01/2010 - 07/2002)|
|6.||Lem, Janis: 3 articles (12/2007 - 01/2003)|
|7.||Berriel Diaz, Mauricio: 2 articles (08/2015 - 04/2011)|
|8.||Rose, Adam J: 2 articles (08/2015 - 04/2011)|
|9.||Sticht, Carsten: 2 articles (08/2015 - 04/2011)|
|10.||Gretz, Norbert: 2 articles (08/2015 - 04/2011)|
12/01/2007 - "A novel form of transducin-dependent retinal degeneration: accelerated retinal degeneration in the absence of rod transducin."
01/01/2003 - "Bright light induces retinal degeneration by a transducin-independent mechanism."
11/01/1994 - "In contrast to other animal models for hereditary retinal degeneration (rd, RCS), a novel feature of the P23H degeneration is an accumulation of rhodopsin, transducin, and PDE within the outer plexiform layer of the retina. "
01/01/1987 - "In order to determine the relationship between different forms of retinal degeneration and the transducin content in the affected retinas, affinity-purified antibodies directed against the individual subunits of bovine transducin were prepared. "
01/01/1997 - "The present study was undertaken to evaluate the gene for the alpha-1 subunit of the rod specific G-protein transducin (GNAT1), a member of the phototransduction pathway, as a candidate for progressive rod cone degeneration (pred) in poodles, early retinal degeneration (erd) in elkhounds, and rod cone dysplasia 2 (rcd2) in collies. "
|2.||Synovial Sarcoma (Synovioma)
10/01/2013 - "Expression of the transducin-like enhancer of split 1 (TLE1) by immunohistochemistry (IHC) has been widely used as a biomarker for the diagnosis of synovial sarcoma. "
02/01/2014 - "ATF2 assembles into a complex with the synovial sarcoma translocation, chromosome 18 (SS18)-synovial sarcoma, X breakpoint (SSX) fusion oncoprotein, and the transducin-like enhancer of split 1 (TLE1) corepressor, driving oncogenesis in synovial sarcoma. "
04/01/2010 - "Our objectives in this study were (1) to test whether the differentially expressed gene, Transducin-Like Enhancer of split (TLE1) belonging to the groucho/TLE family, is also distinct on the protein level; (2) to evaluate this biomarker in a series of well-characterised synovial sarcomas on standard, full-sized tissue sections and (3) to correlate the expression of TLE1 with t(X;18) and other established biomarkers. "
|3.||Deafness (Deaf Mutism)
01/01/2005 - "In the present study, we focused on Transducin beta-like 1Y (TBL1Y), which is a Y-linked homologue of TBL1X that is related with X-linked late-onset sensorineural deafness. "
05/01/2000 - "This complex contains transducin beta-like protein 1 (TBL1), whose gene is mutated in human sensorineural deafness. "
01/01/2012 - "Transducin β-like protein 1 (TBL1) is a candidate gene for ocular albinism with late-onset sensorineural deafness, a form of X-linked age-related hearing loss. "
|4.||Pancreatic Neoplasms (Pancreatic Cancer)
08/01/2015 - "Transcriptional co-factor Transducin beta-like (TBL) 1 acts as a checkpoint in pancreatic cancer malignancy."
11/10/2015 - "In the current study, we demonstrated that upregulation of miR-744 in pancreatic cancer promoted Wnt/β-catenin signaling by directly targeting secreted frizzled-related protein 1 (SFRP1), glycogen synthase kinase 3β (GSK3β), and transducin-like enhancer of split 3 (TLE3), important negative modulators of Wnt/β-catenin signaling. "
07/01/2010 - "In this study, we characterized the TIG1 transducin beta-like gene required for infectious growth and its interacting genes that are required for plant infection in this model phytopathogenic fungus. "
10/01/1987 - "Infection of neuroretinal cells in vitro by avian sarcoma viruses UR1 and UR2: transformation, cell growth stimulation, and changes in transducin levels."
|1.||GTP-Binding Proteins (G-Protein)
|3.||Guanosine Diphosphate (GDP)
|4.||Carrier Proteins (Binding Protein)
|5.||Glycogen Synthase Kinases
|6.||Biological Markers (Surrogate Marker)
|8.||Peptide Elongation Factors (Elongation Factor)